Key statistics
On Friday, Avacta Group PLC (RTQ1:FRA) closed at 0.655, -28.02% below its 52-week high of 0.91, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.655 |
|---|---|
| High | 0.655 |
| Low | 0.655 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.67 |
| Average volume | 600.00 |
|---|---|
| Shares outstanding | 440.42m |
| Free float | 426.19m |
| P/E (TTM) | -- |
| Market cap | 255.44m GBP |
| EPS (TTM) | -0.0891 GBP |
Data delayed at least 15 minutes, as of Feb 13 2026 07:09 GMT.
More ▼
Announcements
- Appointment of CSO
- Avacta appoints Francis Wilson as Chief Scientific Officer
- Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
- Faridoxorubicin Program Clinical Updates
- Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
- FDA Clearance of IND Application for AVA6103
- Avacta Announces Year-end Trading Update
- Year-end trading update
- Appointment of Nominated Adviser & TVR
- Avacta reports new AVA6103 pharmacology data
More ▼
